We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CMS Tightens Its Purse Strings for Phase I, II Clinical Trials
CMS Tightens Its Purse Strings for Phase I, II Clinical Trials
March 4, 2009
Sites that want Medicare to reimburse the cost of products used in Phase I or II clinical trials must make sure the studies clearly indicate therapeutic intent.